Former Nebraska Senator Ben Sasse has recently opened up about his harrowing battle with stage 4 pancreatic cancer, a journey he describes as both painful and enlightening. Diagnosed in mid-December 2025 with what his doctor referred to as a “death sentence,” Sasse has been candid in public forums about his prognosis and the treatments he is undergoing.
:max_bytes(150000):strip_icc():format(jpeg)/Ben-Sasse-62873d10d32a4d959de28f0be681f551.jpg)
In an interview with The New York Times, Sasse, 54, spoke about receiving shocking news that his body was “chock-full of tumours.” With multiple cancers present, including lymphoma and lung cancer, he was informed that surgery was not an option. The diagnosis followed several months of escalating pain that had begun to interfere with his regular training for sprint triathlons. Initially, Sasse believed he might have simply strained a muscle, but the severity of his symptoms pushed him to seek medical attention.
Sasse recalled the moment he received his diagnosis. After a round of scans, he insisted the physician provide a straightforward answer. The revelation was blunt, yet Sasse remained focused on discussing his treatment options. “You have a definite death sentence, but there are some clinical trials that could extend life a little bit,” he recounted. Encouraged by potential new therapies, he began exploring clinical trials across the United States, motivated by the desire to extend his time with his family.
Since his tenure in the Senate, where he served until January 2021, Sasse has taken on the role of president at the University of Florida. However, his treatment has required frequent travels to major cities for clinical trials, recently relocating to Austin, Texas. There, he is navigating his current treatment protocol involving a drug called daraxonrasib, taken orally. While this medication has helped him feel better than he initially expected, it has also led to some troubling side effects, including issues with skin regeneration that result in significant bleeding.
Sasse’s treatment regimen also includes pain management. Initially prescribed 55 milligrams of morphine, he joked about his elevated state during that period, but has since managed to reduce his dosage to 30 milligrams a day. He described experiencing “strong waves of desire to puke” while also coping with frequent bleeding on his face due to the drug’s impact on his body.
His condition has seen some improvement; he reported that his tumours have shrunk by 76% since his treatment began. However, despite these positive signs, Sasse is realistic about his prognosis, realising he faces a challenging and uncertain future. He conveyed feelings of gratitude for the time he still has, stating, “I feel better than I deserve,” but also acknowledging the ongoing battle against new cancer growths.
When discussing the nature of his illness, Sasse likened his treatment to a game of “Whac-A-Mole,” emphasising how new cancerous cells tend to emerge even when others are being managed. The gravity of stage 4 pancreatic cancer cannot be understated, and when asked about survival rates, he responded with sober honesty, stating, “Not from what I have, no.”
As he contemplates his remaining months, Sasse has taken the opportunity to impart wisdom to his children and share insights with the public. In his interview, he expressed the importance of making the most of every moment in light of his diagnosis. “There’s only so many bits of unsolicited advice I can give my children. I want to redeem the time,” he stated.
Despite the toll of his illness and treatment, Sasse is determined to keep a sense of humour and maintain a positive outlook. While the physical challenges of coping with terminal cancer are daunting, his willingness to share this emotional journey provides an important perspective on what it means to face mortality head-on.
In sharing his story, Ben Sasse exemplifies resilience in the face of adversity, encouraging others to find strength and purpose amidst overwhelming circumstances.